0HB4 Stock Chart & Stats
€19.35
-€0.24(-0.69%)
At close: 4:00 PM EST
€19.35
-€0.24(-0.69%)
Day’s Range― - ―
52-Week Range€15.84 - €30.35
Previous CloseN/A
Volume1.01M
Average Volume (3M)713.43K
Market Cap
€26.60B
Enterprise Value€21.33K
Total Cash (Recent Filing)€5.66B
Total Debt (Recent Filing)€3.38B
Price to Earnings (P/E)19.9
Beta0.64
Next Earnings
Oct 28, 2026EPS Estimate
0.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.00
Shares Outstanding1,341,855,700
10 Day Avg. Volume931,839
30 Day Avg. Volume713,426
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)3.57
Price to Sales (P/S)5.04
P/FCF Ratio21.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€22.07Price Target Upside14.06% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)1.33
Revenue Forecast (FY)€6.34B
Bulls Say, Bears Say
Bulls Say
High Profit MarginsDassault Systèmes operates high-margin application software businesses, with sustained gross and operating margins that reflect scalable SaaS/enterprise licensing economics. Durable margins support reinvestment, R&D, and long-term profitability resilience across cycles.
Strengthening Balance SheetMaterial de-leveraging over multiple years has improved financial flexibility, lowering refinancing and interest risk. A stronger capital structure enables strategic M&A, R&D investment, and shareholder returns without materially increasing leverage-related constraints.
Expansion Into Life Sciences SoftwarePursuing ArisGlobal would deepen Dassault's life-sciences vertical capability, diversifying revenue into regulated R&D and trials software. Structural expansion into healthcare software strengthens product portfolio and cross-sell potential into a high-value, sticky market.
Bears Say
Inconsistent Revenue GrowthTop-line momentum has been uneven: a near-flat annual revenue in 2025 signals risk to durable growth assumptions. For a subscription-heavy software firm, inconsistent revenue growth complicates forecasting, resource allocation and long-term scaling of margins.
Weakened Cash Flow MomentumAlthough absolute FCF is sizable, recent sharp negative FCF growth and sub-1x cash conversion suggest timing, working-capital or conversion volatility. Persisting conversion weakness could constrain reinvestment, M&A integration funding, or durable shareholder returns.
End-market Cyclicality ExposureServing cyclical industrial sectors means demand for licenses, services and implementations can swing with capital spending cycles. Structural exposure to capital goods and mobility industries can lead to multi-quarter volatility in renewals and professional services revenue.
0HB4 FAQ
What was Dassault Systemes SE’s price range in the past 12 months?
Dassault Systemes SE lowest share price was €15.84 and its highest was €30.35 in the past 12 months.
What is Dassault Systemes SE’s market cap?
Dassault Systemes SE’s market cap is €26.60B.
When is Dassault Systemes SE’s upcoming earnings report date?
Dassault Systemes SE’s upcoming earnings report date is Oct 28, 2026 which is in 93 days.
How were Dassault Systemes SE’s earnings last quarter?
Dassault Systemes SE released its earnings results on Jul 23, 2026. The company reported €0.31 earnings per share for the quarter, beating the consensus estimate of €0.299 by €0.011.
Is Dassault Systemes SE overvalued?
According to Wall Street analysts Dassault Systemes SE’s price is currently Undervalued.
Does Dassault Systemes SE pay dividends?
Dassault Systemes SE does not currently pay dividends.
What is Dassault Systemes SE’s EPS estimate?
Dassault Systemes SE’s EPS estimate is 0.31.
How many shares outstanding does Dassault Systemes SE have?
Dassault Systemes SE has 1,341,855,700 shares outstanding.
What happened to Dassault Systemes SE’s price movement after its last earnings report?
Dassault Systemes SE reported an EPS of €0.31 in its last earnings report, beating expectations of €0.299. Following the earnings report the stock price went up 2.704%.
Which hedge fund is a major shareholder of Dassault Systemes SE?
Currently, no hedge funds are holding shares in GB:0HB4
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Dassault Systemes SE
Dassault Systèmes SE, established in 1981 and based in Vélizy-Villacoublay, France, operates globally as a premier provider of sophisticated software platforms and related professional services. The company's extensive product suite caters to a broad spectrum of industry requirements. Among its flagship applications are SOLIDWORKS, a versatile toolkit for 3D design, electrical and printed circuit board schematics, product data management, simulation, manufacturing processes, and technical communication; CATIA, an engineering and design powerhouse for 3D computer-aided design; GEOVIA, specifically developed for modeling and simulating the Earth; and BIOVIA, empowering the scientific community with advanced tools for biological, chemical, and materials experiences. The portfolio further includes SIMULIA, which delivers highly realistic simulation capabilities; DELMIA, designed to optimize global industrial operations; 3DVIA, providing innovative 3D space planning solutions; and ENOVIA, instrumental in planning and monitoring the criteria for customer success. Additional offerings comprise Centric PLM, a dedicated product lifecycle management software; 3DEXCITE, for cutting-edge real-time 3D visualization; and NETVIBES, which assists organizations in collecting, structuring, and enhancing big data. Central to their ecosystem is the 3DEXPERIENCE platform, an integrated environment that grants businesses a holistic and real-time overview of their activities and wider ecosystem, effectively linking individuals, concepts, data, and solutions. Furthermore, MEDIDATA offers specialized clinical research study software, furnishing crucial evidence and insights to pharmaceutical, biotech, medical device, and diagnostic firms, alongside academic researchers. Beyond software, Dassault Systèmes provides comprehensive services such as consulting, deployment assistance, outcome-based solutions, and training. The company's diverse clientele spans numerous industries, including transportation and mobility, industrial equipment, aerospace and defense, high-tech, life sciences and healthcare, energy and materials, home and lifestyle, construction, cities and territories, consumer packaged goods and retail, marine and offshore, and various business services. These solutions reach customers primarily through a robust network of distributors and resellers.
0HB4 Stock 12 Month Forecast
Average Price Target
€22.07
▲(14.06% Upside)
Technical Analysis
Lectra SA
―
SWORD GROUP SE
―
Acteos SA
―
Magillem Design Services SA
―
Planisware Societe anonyme
―